1. Home
  2. TEX vs KYMR Comparison

TEX vs KYMR Comparison

Compare TEX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$57.82

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$78.78

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
KYMR
Founded
1933
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
7.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TEX
KYMR
Price
$57.82
$78.78
Analyst Decision
Buy
Strong Buy
Analyst Count
10
26
Target Price
$68.80
$107.72
AVG Volume (30 Days)
1.1M
440.4K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
1.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,421,000,000.00
$39,211,000.00
Revenue This Year
$47.67
$10.61
Revenue Next Year
$6.66
$8.17
P/E Ratio
N/A
N/A
Revenue Growth
5.73
N/A
52 Week Low
$41.70
$28.06
52 Week High
$71.50
$103.00

Technical Indicators

Market Signals
Indicator
TEX
KYMR
Relative Strength Index (RSI) 42.42 40.35
Support Level $54.46 $77.71
Resistance Level $58.66 $89.80
Average True Range (ATR) 2.67 3.23
MACD -0.66 -0.58
Stochastic Oscillator 28.45 14.38

Price Performance

Historical Comparison
TEX
KYMR

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: